IAC Webinars 2022

The next webinar is planned for Wednesday, August 31st 2022. 2PM Central European Summer Time (Amsterdam)

Previous Webinars can be viewed at the IAC YouTube channel.

What´s new in salivary gland FNA: Updates to the Milan System. Dr. William F. Faquin, MD, PhD

Salivary gland cytology presents diagnostic challengeds,  but recent advances have helped to refine this process. The Second Edition of the Milan System includes a streamlined, unform reporting system for salivary gland FNA with revised ROM´s for each diagnostic catagory, and it incorporates the latesst ancillary markers and molecular profiles to increase the accuracy of salivary FNA. In addition, an emphasis is placed on correlating salivary gland FNA with image analysis and with a clinical management algorithm. Taken together, these advances have helped to significantly improve the effectiveness of salivary gland FNA and lead to better overall patient care.

The webinar will be over Zoom. Wednesday, August 31, 2000. 2PM Central European Summer Time

Link to Zoom:

Meeting ID: 810 1975 7659
Passcode: 032837

WC Faquin 2022

Dr. Faquin is the Chief of Otolaryngologic Pathology at the Massachusetts Eye and Ear and a subspecialist in Head and Neck Pathology & Cytopathology at the Massachusetts General Hospital in Boston. He is Professor of Pathology at Harvard Medical School, and is recognized for his contributions to the study of thyroid, salivary gland, and HPV-related cancers of the head and neck. He has authored over 370 peer-reviewed publications, and has co-authored several books on head and neck cytohistology, salivary gland cytopathology, and thyroid cytopathology. Dr. Faquin is the Editor-in-Chief for Cancer Cytopathology which is one of the 3 journals of the American Cancer Society, he is an author of the upcoming ARP Fascicle for Upper Aerodigestive Tract Tumors, co-author of the Bethesda System for Reporting Thyroid Cytopathology, co-chair of the College of American Pathologists Evidence-Based Guidelines Committee for the testing of head and neck squamous cell carcinomas for high-risk HPV, and co-chair of the Milan System for Reporting Salivary Gland Cytopathology sponsored by the ASC and IAC.

Return to top